- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 355
Mail.ru collects Zakazaka for $18m
Mail.ru has acquired the remaining 90% stake in food delivery platform and portfolio company Zakazaka in a deal that valued the startup at $20m.
May 11, 2017River Vision flows into Horizon in $145m deal
Horizon Pharma has agreed to pay $145m upfront to buy River Vision Development Corp, enabling GlaxoSmithKline and Lundbeck to exit.
May 10, 2017Corporate investment bears fruits in Persimmon acquisition
Intel, ABB and Nidec Sankyo have exited Persimmon Technologies in an acquisition by Sumitomo Heavy Industries valued at almost $32m.
May 9, 2017Shotspotter targets public markets
The Motorola Solutions-backed gunshot detection software provider plans to raise up to $34.5m in an initial public offering on Nasdaq.
May 9, 2017Affinitas finds a Spark with merger deal
Affinitas is set to merge with fellow online dating company Spark Networks in a deal that will provide an exit to Rocket Internet and Medienguppe Pressedruck.
May 8, 2017Ovid invades public markets with $75m IPO
The neurological disorder drug developer has floated in an initial public offering that gave pharmaceutical companies Sanofi and Takeda exits.
May 8, 2017Intel exits as Quotient eats Crisp
The transaction, worth up to $57.5m, will allow Intel Capital and the Singapore state-owned EDBI to exit adtech provider Crisp Media.
May 5, 2017Whirlpool swallows up recipe platform Yummly
Intel, Unilever and Bauer Media will exit online recipe recommendation platform Yummly, which was valued at $100m as of 2015, in an acquisition by appliance maker Whirlpool.
May 4, 2017Yik Yak's founders give up the ghost
The Renren-backed social media platform has formally announced it will shut down this week, with Square paying about $1m for some of its engineers and IP.
May 4, 2017Zymeworks zooms to public markets
The cancer-focused antibody developer has secured $58.5m in a US flotation that involved existing investors Celgene and Eli Lilly buying more than $7m of shares.
May 3, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


